CEFEXOL 400MG CAP 5s
Cefixime 400mg capsules exhibit their antibacterial activity through a specific mechanism of action. Cefixime primarily inhibits bacterial cell wall synthesis by binding to and blocking the activity of penicillin-binding proteins (PBPs), which are essential enzymes responsible for cross-linking peptidoglycan strands in the bacterial cell wall. By inhibiting PBPs, Cefixime disrupts the formation of a strong and stable cell wall, leading to weakened bacterial cell structure and ultimately cell lysis. This mechanism is particularly effective against susceptible bacteria, as it interferes with a vital process required for their growth and survival. Ingredients Cefixime 400mg Drug Class Cephalosporin antibiotic Dosage Form Capsule Uses The following are the uses of Cefixime 400mg Capsule: Used for treating bacterial infections, particularly those caused by susceptible bacteria. Used for respiratory tract infections like pneumonia and bronchitis. Used for treating urinary tract infections, effectively eliminating bacteria. Used for skin and soft tissue infections, promoting healing. Used for bone and joint infections, providing targeted treatment. Used for preventing and controlling infections during surgery. Used for managing severe infections that require high-dose antibiotics. Dosage Dose must be taken according to doctor’s advice only; doses given below are suggested as supportive literature for better understanding in some areas of requirements. Adult dose (For chronic bronchitis, otitis media, gonorrhea, urinary tract infection): 400mg daily divided dose every 12 to 24 hours. Pediatric dose (For Chronic Bronchitis, Otitis media, Pharyngitis, Tonsillitis, Gonorrhea, Urinary tract infection): Children of age 6 months to 12 years, body weight is not more than 45kg; then take 8mg/kg/day in single dose or in divided doses after 12 hours. For 12 years above age: weight is more than 45kg; then take 400mg once.
Variants (1)
- Default Title — 420.00 PKR — In stock
AI Readiness
Good foundation, but some important product data is still missing.